- Thomas, E. D., Storb, R., Clift, R. A., Fefer, A., Johnson, F. L., Neiman, P. E., Lerner, K. G., Glucksberg, H. and Buckner, C. D. (1975) "Bone marrow transplantation", New England Journal of Medicine 292, 832-843.
- Dugan, M. J., DeFor, T. E., Steinbuch, M., Filipovich, A. H. and Weisdorf, D. J. (1997)" ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival", Annals of Hematology 75, 41-46.
- Wagner, J. E. (1992) "Prevention of graft failure by cyclosporine in rats receiving lymphocyte-depleted MHC-mismatched bone marrow". Transplantation 53, 624-628.
- D'Costa, S. and Hurwitz, J. L. (2002) "Antibody and pre-plus post transplant prednisone treatments support T cell-depleted stem cell engraftment without drug-induced morbidity", Bone Marrow Transplantation 29, 553-556.
- Schlegel, P. G., Eyrich, M., Bader, P., Handgretinger, R., Lang, P., Niethammer, D. and Klingebiel, T. (2000) "OKT3-based reconditioning regimen for early graft failure in HLA-non-identical stem cell transplants", British Journal of Haematology 111, 668-673.
- Anel, A., Buferne, M., Boyer, C., Schmitt-Verhulst, A.-M. and Golstein, P. (1994) "T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A", European Journal of Immunology 24, 2469-2476.
- Dzialo-Hatton, R., Milbrandt, J., Hockett, R. D. and Weaver, C. T. (2001) "Differential expression of Fas ligand in TH1 and TH2 cells is regulated by early growth response gene and NF-AT family members", Journal of Immunology 166, 4534-4542.
- Mittelstadt, P. R. and Ashwell, J. D. (1998) "Cyclosporine-sensitive transcription factor Egr-3 regulates Fas ligand expression", Molecular Cell Biology 18, 3744-3751.
- Scudeletti, M., Lanza. L., Monaco, E., Monetti, M., Puppo, F., Filcai, G. and Indiveri, F. (1999) "Immune regulatory properties of corticosteroids: prednisone induces apoptosis of human T lymphocytes following the CD3 down-regulation", Annals of New York Academy of Sciences 876, 164-179.
- Ito, C., Ribeiro, R. C., Behm. F. G., Raimondi. S. C., Pui. C. H. and Campana, D. (1998) "Cyclosporine A induces apoptosis in childhood ALL cells", Blood 91, 1001-1007.
- Gaynon, P. S. and Lustig. R. H. (1995) "The use of glucocorticoids in acute lymphoblastic leukemia of childhood. Molecular, cellular, and clinical considerations", Journal of Pediatric Hematology and Oncology 17, 1-12.
- Ohnoshi, T., Hayashi, K., Mizuta, J., Tagawa. S., Matsutomo. S., Saito, S., Kawashima, K., Akagi, T. and Kimura. I. (1993) "Brief induction chemotherapy followed by involved-field irradiation for the treatment of localized intermediate- and high-grade non-Hodgkin's lymphoma", International Journal of Hematology 57, 61-66.
- Kappler, J. W., Skidmore, B., White, J. and Marrack, P. (1981) "Antigen-inducible, H-2-restricted interleukin-2-producing T cell hybridomas: lack of independent antigen and H-2 recognition", Journal of Experimental Medicine 153, 1198-1214.
- Locatelli, F., Zecca, M., Rondelli, R., Bonetti, F., Dini, G., Prete, A., Messina, C., Uderzo, C., Ripaldi, M., Porta, F., Giorgiani, G., Giraldi, E. and Pession, A. (2000) "Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial", Blood 95, 1572-1579.
- Feinstein, L., Sandmaier, B., Maloney, D., McSweeney, P. A., Maris, M., Flowers, C., Radich, R., Little, M. T., Nash, R. A., Chauncey, T., Woolfrey, A., Georges, G., Kiem, H. P., Zaucha, J. M., Blume, K. G., Shizuru, J., Niederwieser, D. and Storb, R. (2001) "Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect", Annals of New York Academy of Sciences 938, 328-337.
Do the Immunosuppressive Drugs used as Treatment for Graft-versus-host Disease Directly Inhibit Lymphoid Tumor Cell Growth?
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.